Wednesday, 11 December 2019

BioLargo Discusses Its 2020 Growth Strategy with the Stock Day Podcast




Phoenix, Arizona--(Newsfile Corp. - December 11, 2019) - The Stock Day Podcast hosted BioLargo Inc. (OTCQB: BLGO) ("the Company"), developer of sustainable products and a full-service environmental engineering company for an interview. President & CEO of BioLargo, Dennis P. Calvert, joined Stock Day host Everett Jolly.
Mr. Calvert began the interview by sharing that the Company was recently named 2019 Cleantech Company of The Year by Sustain SoCal, a leading cleantech industry advocacy group in Southern California.
Mr. Jolly and Mr. Calvert then discussed the recently announced third-party study that validated the ability of BioLargo's CupriDyne® Clean industrial odor and VOC control product to eliminate the toxic air contaminant hydrogen sulfide. Mr. Calvert explained that Southern Air Solutions, an experienced third-party laboratory, validated that CupriDyne Clean results in instantaneous elimination of hydrogen sulfide. "[Hydrogen sulfide] is a really dangerous gas. [At high] concentration, it threatens human life," explained Mr. Calvert. "On contact we can destroy it," added Mr. Calvert.
At the close of the interview, Mr. Calvert shared his expectations for 2020. "We've averaged about 25% quarter-over-quarter growth for the past three years," said Mr. Calvert. He further explained that revenue and cash flow [improvements are] expected to continue. "I'd like to exceed it, but that's probably a function of leverage and some capital to grow infrastructure," said Mr. Calvert. He then updated listeners on the Company's involvement with the PFAS (per- and polyfluoroalkyl substances) crisis, which represents a significant opportunity for the Company. BioLargo Engineering has recently developed a novel technology with the potential to provide an effective, cost-efficient solution to remove PFAS from water, and Mr. Calvert expects this technology to play a big role in solving the global challenge of eliminating these harmful contaminants from water.
"We're pretty excited about the future. 2020 is going to be a great year," closed Mr. Calvert.
To hear Dennis Calvert's entire interview, follow the link to the podcast here: https://audioboom.com/posts/7448805-biolargo-discusses-its-2020-growth-strategy-with-the-stock-day-podcast
Investors Hangout is a proud sponsor of "Stock Day," and Stock Day Media encourages listeners to visit the company's message board at https://investorshangout.com/
About BioLargo, Inc.
BioLargo, Inc. is an innovative technology developer and environmental engineering company driven by a mission to "make life better" by delivering robust, sustainable solutions for a broad range of industries and applications, with a focus on clean water, clean air, and advanced wound care. We develop and commercialize disruptive technologies by providing the capital, support, and expertise to expedite them from "cradle" to "maturity" (www.biolargo.com). Our engineering division features experienced professional engineers dedicated to integrity, reliability, and environmental stewardship (www.biolargoengineering.com). Our industrial odor control division, Odor-No-More (www.odornomore.com) features CupriDyne Clean Industrial Odor Eliminator (www.cupridyne.com), which eliminates the odor-causing compounds and VOCs rather than masking them, and is now winning over leading companies in the solid waste handling and wastewater industries and other industries that contend with malodors and VOCs. Our subsidiary BioLargo Water (www.biolargowater.ca) develops the Advanced Oxidation System "AOS," a disruptive industrial water treatment technology designed to eliminate waterborne pathogens and recalcitrant contaminants with better energy-efficiency and lower operational costs than incumbent technologies. Our subsidiary Clyra Medical (www.clyramedical.com) features effective and gentle solutions for chronic infected wounds to promote infection control and regenerative tissue therapy.
Contact Information
Dennis Calvert President and CEO BioLargo, Inc. 888-400-2863
Safe Harbor Act
This press release includes "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Actual results may differ from expectations, estimates and projections and, consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as "expect," "estimate," "project," "budget," "forecast," "anticipate," "intend," "plan," "may," "will," "could," "should," "believes," "predicts," "potential," "continue," and similar expressions are intended to identify such forward-looking statements. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results.
About The "Stock Day" Podcast
Founded in 2013, Stock Day is the fastest growing media outlet for Nano-Cap and Micro-Cap companies. It educates investors while simultaneously working with penny stock and OTC companies, providing transparency and clarification of under-valued, under-sold Micro-Cap stocks of the market. Stock Day provides companies with customized solutions to their news distribution in both national and international media outlets. The Stock Day Podcast is the number one radio show of its kind in America. Stock Day recently launched its Video Interview Studio located in Phoenix, Arizona.
SOURCE:
Stock Day Media
602-441-3474
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/50693

Tuesday, 10 December 2019

BioLargo LD Micro Main Event XII Presentation Slides

The following is the corporate presentation deck that was delivered by BioLargo President & CEO Dennis P. Calvert on December 10, 2019 at the LD Micro Main Event XII in LA. 


BioLargo’s CupriDyne Clean Proven Effective in Eliminating Hydrogen Sulfide Through Third-Party Lab Testing

Westminster, CA – December 10, 2019 – BioLargo, Inc. (OTCQB:BLGO) (“the Company”), developer of sustainable products and a full-service environmental engineering company, today announced that its patented odor and VOC control product CupriDyne® Clean has been proven effective in eliminating H2S (hydrogen sulfide) in third-party tests conducted by certified testing laboratory Southern Air Solutions Corp (SAS).  

Hydrogen sulfide is a toxic air contaminant found in many industries including landfills, oil and gas drilling and refining, shipping, and wastewater treatment, and is a leading cause of substance inhalation-related workplace deaths. Hydrogen sulfide is also highly corrosive and prolonged exposure can cause damage to pipes and equipment. Industrial operations that produce significant concentrations of hydrogen sulfide are required by Federal law to implement measures to monitor, mitigate, and reduce the production of the compound by their operations. 

The SAS study confirms the oxidation of hydrogen sulfide gas, which validates the company’s real-world experiences with client operationsOdor-No-More, Inc. President Joseph Provenzano commentedHydrogen sulfide is an extremely widespread air contaminant across countless industries, and operators are required to reduce and mitigate it to protect workersThis study provides scientific evidence to support our field experience, proves CupriDyne Clean is eliminating rather than masking these odors, and is an important validation of our product for industries coping with these issues.  

BioLargo President Dennis P. Calvert commented, “This study and CupriDyne Clean are also a valuable tool to our engineering team, who are proven experts in air quality science and solutionsWe expect them to play a big role in achieving broad acceptance of CupriDyne Clean as a solution for this enormous air quality control market application. 

In business since 1989, SAS personnel have more than 60 years combined experience exclusively providing air quality services to the power, petroleum, and chemical industries.  


About BioLargo, Inc. 
BioLargo, Inc. is an innovative technology developer and environmental engineering company driven by a mission to "make life better" by delivering robust, sustainable solutions for a broad range of industries and applications, with a focus on clean water, clean air, and advanced wound care. We develop and commercialize disruptive technologies by providing the capital, support, and expertise to expedite them from "cradle" to "maturity" (www.biolargo.com). Our engineering division features experienced professional engineers dedicated to integrity, reliability, and environmental stewardship (www.biolargoengineering.com). Our industrial odor control division, Odor-No-More (www.odornomore.com) features CupriDyne Clean Industrial Odor Eliminator (www.cupridyne.com), which eliminates the odor-causing compounds and VOCs rather than masking them, and is now winning over leading companies in the solid waste handling and wastewater industries and other industries that contend with malodors and VOCs. Our subsidiary BioLargo Water (www.biolargowater.ca) develops the Advanced Oxidation System "AOS," a disruptive industrial water treatment technology designed to eliminate waterborne pathogens and recalcitrant contaminants with better energy-efficiency and lower operational costs than incumbent technologies. Our subsidiary Clyra Medical (www.clyramedical.com) features effective and gentle solutions for chronic infected wounds to promote infection control and regenerative tissue therapy. 

Contact Information 
Dennis Calvert President and CEO BioLargo, Inc. 888-400-2863 

Safe Harbor Act 
This press release includes “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Actual results may differ from expectations, estimates and projections and, consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as “expect,” “estimate,” “project,” “budget,” “forecast,” “anticipate,” “intend,” “plan,” “may,” “will,” “could,” “should,” “believes,” “predicts,” “potential,” “continue,” and similar expressions are intended to identify such forward-looking statements. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results. 

Thursday, 5 December 2019

BioLargo Awarded 2019 Cleantech Company of the Year by Sustain SoCal


Westminster, CA – December 5th, 2019 – BioLargo, Inc. (OTCQB:BLGO) (“the Company”), developer of sustainable products and a full-service environmental engineering company, today announced that it was named “Cleantech Company of the Year” for 2019 by Sustain SoCal, a leading cleantech industry advocacy organization in Southern California (https://sustainsocal.org/). The award was presented to BioLargo last night at Sustain SoCal’s Annual Holiday Gathering.

This award is given to a company that has reached a high level of achievement with their efforts to assure a more sustainable future through innovation and innovative approaches to sustainability challenges. BioLargo was selected for the award because of its focus on developing innovative solutions to some of the world’s toughest sustainability problems including per- and polyfluoroalkyl substance (PFAS) contamination, energy efficient water treatment solutions, environmentally friendly air quality control solutions, and more.

Sustain SoCal President Scott Kitcher said of the award, “BioLargo exemplifies a technology company paving the way toward solutions to environmental issues. We are proud and delighted to give this award to BioLargo for its hard work addressing serious sustainability challenges.”

Dennis Calvert, Joseph Provenzano, Scott Kitcher
BioLargo President & CEO Dennis P. Calvert commented, “2019 was a tremendous year for BioLargo’s burgeoning sustainable cleantech products and services, and we are grateful to Sustain SoCal for recognizing us as the 2019 Cleantech Company of the Year. Our AOS clean water technology was deployed in several demonstration pilots where its energy efficient water treatment capabilities were proven in real-life settings. Our engineering division developed a novel and powerful treatment technology with the potential to help solve the global PFAS contamination crisis, and began serving seven United States Air Force bases with environmental engineering services. And our odor and VOC control division hit record sales numbers, setting the stage for us to serve an ever-growing number of air quality customers in 2020. We also topped all this off with the successful FDA 510(K) clearance for our first advanced wound care product.”

About BioLargo, Inc.
BioLargo, Inc. is an innovative technology developer and environmental engineering company driven by a mission to "make life better" by delivering robust, sustainable solutions for a broad range of industries and applications, with a focus on clean water, clean air, and advanced wound care. We develop and commercialize disruptive technologies by providing the capital, support, and expertise to expedite them from "cradle" to "maturity" (www.biolargo.com). Our engineering division features experienced professional engineers dedicated to integrity, reliability, and environmental stewardship (www.biolargoengineering.com). Our industrial odor control division, Odor-No-More (www.odornomore.com) features CupriDyne Clean Industrial Odor Eliminator (www.cupridyne.com), which eliminates the odor-causing compounds and VOCs rather than masking them, and is now winning over leading companies in the solid waste handling and wastewater industries and other industries that contend with malodors and VOCs. Our subsidiary BioLargo Water (www.biolargowater.ca) develops the Advanced Oxidation System "AOS," a disruptive industrial water treatment technology designed to eliminate waterborne pathogens and recalcitrant contaminants with better energy-efficiency and lower operational costs than incumbent technologies. Our subsidiary Clyra Medical (www.clyramedical.com) features effective and gentle solutions for chronic infected wounds to promote infection control and regenerative tissue therapy.

About Sustain SoCal
Sustain Southern California (Sustain SoCal - https://sustainsocal.org/) accelerates cleantech economic growth and sustainability initiatives through innovation, collaboration and education. As Southern California's population, industry, workforce and tourism continues to grow and change, it is vitally important to proactively address the region's sustainability, environmental and infrastructure needs and objectives. Formerly known as Cleantech OC and Sustain OC, Sustain SoCal has a long history of exploring and implementing pragmatic, real-world solutions to the challenges created by growth, change and inefficiency that face Southern California and beyond. Sustain SoCal conducts conferences, workshops and networking events to help in the sharing of knowledge and establish connections that have a positive impact on both the economic progress and sustainable future of the area and its residents, businesses and visitors. For key sectors such as Energy, Water, Transportation, Hospitals / Healthcare and Waste Stream Management, Sustain SoCal has gathered together stakeholders and formed Sustainability Networks are collaborating towards seeking common solutions and enabling economic growth. Working Groups within each Sustainability Network focus on specific issues and challenges that can be addressed through innovation and economic opportunities. Sustain SoCal participants and sponsors range from established and emerging cleantech companies, start-up companies, corporate organizations of all sizes, municipal / regional / state / national agencies and governments, schools, hospitals, non-profit organizations, investors and more.

Contact Information
Dennis Calvert President and CEO BioLargo, Inc. 888-400-2863

Safe Harbor Act
This press release includes “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Actual results may differ from expectations, estimates and projections and, consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as “expect,” “estimate,” “project,” “budget,” “forecast,” “anticipate,” “intend,” “plan,” “may,” “will,” “could,” “should,” “believes,” “predicts,” “potential,” “continue,” and similar expressions are intended to identify such forward-looking statements. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results.


BioLargo to Present at the LD Micro Main Event (XII)

LOS ANGELES, CA / ACCESSWIRE / December 5, 2019 / LD Micro, an independent resource for microcap company news, announced that BioLargo, Inc. (OTCQB:BLGO), developer of sustainable products and a full-service environmental engineering company, will be presenting at the 12th annual LD Micro Main Event on Tuesday, December 10th at 3:00 PM PST / 6:00 PM EST. BioLargo's President & CEO Dennis P. Calvert will be presenting and meeting with investors.
BioLargo has made significant commercial strides in 2019. The company secured FDA 510(K) approval for its subsidiary Clyra Medical Technologies' first advanced wound care product, delivered and installed demonstration pilots for its patented water treatment technology the Advanced Oxidation System (AOS), and grew sales of its odor and VOC control products and services substantially, hitting new revenue records.
BioLargo President & CEO Dennis P. Calvert commented, "We look forward to discussing recent milestones, including our new PFAS treatment technology, the environmental engineering services BioLargo Engineering is now providing to seven United States Air Force bases, and that we believe we are on track to break new sales records this quarter based on our current performance trends, setting the stage for a great close-out to 2019."
Chris Lahiji, President of LD Micro, states, "This year's Main Event is our largest event to date, with 275 companies set to present and meet with investors. Even though LD has emerged as one of the largest and most influential organizations in the space, our focus has never deviated from showcasing some of the more interesting businesses in the world to our ever-growing community. Investor interest in our events has also never been stronger, and that goes for our commitment to philanthropy as well."
The LD Micro Main Event will take place on December 10th-12th in Los Angeles, at the Luxe Sunset Bel Air Hotel, which will feature 275 companies, and will be attended by over 1,400 individuals.
View BioLargo's profile here: http://www.ldmicro.com/profile/BLGO
Profiles powered by LD Micro - News Compliments of Accesswire
About BioLargo, Inc.
BioLargo, Inc. is an innovative technology developer and environmental engineering company driven by a mission to "make life better" by delivering robust, sustainable solutions for a broad range of industries and applications, with a focus on clean water, clean air, and advanced wound care. We develop and commercialize disruptive technologies by providing the capital, support, and expertise to expedite them from "cradle" to "maturity" (www.biolargo.com). Our engineering division features experienced professional engineers dedicated to integrity, reliability, and environmental stewardship (www.biolargoengineering.com). Our industrial odor control division, Odor-No-More (www.odornomore.com) features CupriDyne Clean Industrial Odor Eliminator (www.cupridyne.com), which eliminates the odor-causing compounds and VOCs rather than masking them, and is now winning over leading companies in the solid waste handling and wastewater industries and other industries that contend with malodors and VOCs. Our subsidiary BioLargo Water (www.biolargowater.ca) develops the Advanced Oxidation System "AOS," a disruptive industrial water treatment technology designed to eliminate waterborne pathogens and recalcitrant contaminants with better energy-efficiency and lower operational costs than incumbent technologies. Our subsidiary Clyra Medical (www.clyramedical.com) features effective and gentle solutions for chronic infected wounds to promote infection control and regenerative tissue therapy.
About LD Micro
LD Micro was founded in 2006 with the sole purpose of being an independent resource in the microcap space.
What started out as a newsletter highlighting unique companies has transformed into several influential events annually (Invitational, Summit, and Main Event).
In 2015, LDM launched the first pure microcap index (the LDMi) to exclusively provide intraday information on the entire sector. LD will continue to provide valuable tools for the benefit of everyone in the small and micro-cap universe.
For those interested in attending, please contact David Scher at david@ldmicro.com or visit www.ldmicro.com for more information.
Contact:
Name: Dennis P. Calvert, CEO of BioLargo
Phone: 888-400-2863
Address: 14921 Chestnut Street, Westminster, CA, 92683
Email: dennis.calvert@biolargo.com
SOURCE: BioLargo, Inc. via LD Micro